127 related articles for article (PubMed ID: 17067006)
1. Carcinogenesis and the hypothesis of phylogenetic reversion.
Bartels PH; Ranger-Moore J; Alberts D; Hess L; Scarpelli M; Montironi R
Anal Quant Cytol Histol; 2006 Oct; 28(5):243-52. PubMed ID: 17067006
[TBL] [Abstract][Full Text] [Related]
2. Carcinogenesis and the hypothesis of phylogenetic reversion.
Blanca A; Requena MJ; Carrasco JC
Anal Quant Cytol Histol; 2007 Dec; 29(6):379-80. PubMed ID: 18225395
[No Abstract] [Full Text] [Related]
3. Epigenetic silencing of occludin promotes tumorigenic and metastatic properties of cancer cells via modulations of unique sets of apoptosis-associated genes.
Osanai M; Murata M; Nishikiori N; Chiba H; Kojima T; Sawada N
Cancer Res; 2006 Sep; 66(18):9125-33. PubMed ID: 16982755
[TBL] [Abstract][Full Text] [Related]
4. Emerging roles of heterogeneous nuclear ribonucleoprotein K (hnRNP K) in cancer progression.
Barboro P; Ferrari N; Balbi C
Cancer Lett; 2014 Oct; 352(2):152-9. PubMed ID: 25016060
[TBL] [Abstract][Full Text] [Related]
5. Epigenetics in carcinogenesis and cancer prevention.
Jones PA
Ann N Y Acad Sci; 2003 Mar; 983():213-9. PubMed ID: 12724226
[TBL] [Abstract][Full Text] [Related]
6. [Promoter hypermethylation and CpG island methylator phenotype in colorectal carcinogenesis].
Matsubara N
Gan To Kagaku Ryoho; 2010 Sep; 37(9):1659-64. PubMed ID: 20841928
[TBL] [Abstract][Full Text] [Related]
7. Epigenetic drugs as pleiotropic agents in cancer treatment: biomolecular aspects and clinical applications.
Sigalotti L; Fratta E; Coral S; Cortini E; Covre A; Nicolay HJ; Anzalone L; Pezzani L; Di Giacomo AM; Fonsatti E; Colizzi F; Altomonte M; Calabrò L; Maio M
J Cell Physiol; 2007 Aug; 212(2):330-44. PubMed ID: 17458893
[TBL] [Abstract][Full Text] [Related]
8. Epigenetic regulation of cancer stem cell gene expression.
Bapat SA
Subcell Biochem; 2013; 61():419-34. PubMed ID: 23150261
[TBL] [Abstract][Full Text] [Related]
9. Action at a distance: epigenetic silencing of large chromosomal regions in carcinogenesis.
Clark SJ
Hum Mol Genet; 2007 Apr; 16 Spec No 1():R88-95. PubMed ID: 17613553
[TBL] [Abstract][Full Text] [Related]
10. Epigenetic silencing of the MGMT gene in cancer.
Soejima H; Zhao W; Mukai T
Biochem Cell Biol; 2005 Aug; 83(4):429-37. PubMed ID: 16094446
[TBL] [Abstract][Full Text] [Related]
11. Epigenetic silencing mediated by CpG island methylation: potential as a therapeutic target and as a biomarker.
Teodoridis JM; Strathdee G; Brown R
Drug Resist Updat; 2004; 7(4-5):267-78. PubMed ID: 15533764
[TBL] [Abstract][Full Text] [Related]
12. DNA methylation and histone modifications in patients with cancer: potential prognostic and therapeutic targets.
Herranz M; Esteller M
Methods Mol Biol; 2007; 361():25-62. PubMed ID: 17172706
[TBL] [Abstract][Full Text] [Related]
13. Frequent silencing of RASSF1A via promoter methylation in follicular thyroid hyperplasia: a potential early epigenetic susceptibility event in thyroid carcinogenesis.
Brown TC; Juhlin CC; Healy JM; Prasad ML; Korah R; Carling T
JAMA Surg; 2014 Nov; 149(11):1146-52. PubMed ID: 25229773
[TBL] [Abstract][Full Text] [Related]
14. Epigenetic changes in cancer.
Iacobuzio-Donahue CA
Annu Rev Pathol; 2009; 4():229-49. PubMed ID: 18840073
[TBL] [Abstract][Full Text] [Related]
15. Neuroendocrine lung carcinogenesis in hamsters is inhibited by green tea or theophylline while the development of adenocarcinomas is promoted: implications for chemoprevention in smokers.
Schuller HM; Porter B; Riechert A; Walker K; Schmoyer R
Lung Cancer; 2004 Jul; 45(1):11-8. PubMed ID: 15196729
[TBL] [Abstract][Full Text] [Related]
16. Cancer: an epigenetic landscape.
Dhanasekaran K; Arif M; Kundu TK
Subcell Biochem; 2013; 61():399-417. PubMed ID: 23150260
[No Abstract] [Full Text] [Related]
17. MPP3 inactivation by promoter CpG islands hypermethylation in colorectal carcinogenesis.
Feng X; Chen K; Ye S; Wang H; Wei G; Tan W; Cheng S; Zhang Y; Liu S; Zhou Y
Cancer Biomark; 2012; 11(2-3):99-106. PubMed ID: 23011156
[TBL] [Abstract][Full Text] [Related]
18. Stochastic gene expression, disruption of tissue averaging effects and cancer as a disease of development.
Capp JP
Bioessays; 2005 Dec; 27(12):1277-85. PubMed ID: 16299757
[TBL] [Abstract][Full Text] [Related]
19. The role of human adult stem cells and cell-cell communication in cancer chemoprevention and chemotherapy strategies.
Trosko JE; Chang CC; Upham BL; Tai MH
Mutat Res; 2005 Dec; 591(1-2):187-97. PubMed ID: 16084532
[TBL] [Abstract][Full Text] [Related]
20. Genetic and epigenetic heterogeneity in cancer: a genome-centric perspective.
Heng HH; Bremer SW; Stevens JB; Ye KJ; Liu G; Ye CJ
J Cell Physiol; 2009 Sep; 220(3):538-47. PubMed ID: 19441078
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
